In endometrial cancer, FOXA1 is important for inhibition of cell proliferation and migration[24], and in prostate cancer cell lines FOXA1 was recently shown to inhibit cell motility and epithelial to mesenchymal transition (EMT) through regulation of the transcription factor SLUG[17]. This evidence concerns the gene SNAI2 and prostate carcinoma.